Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

ICU Medical, Inc. (ICUI) had Revenue of $2.26B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$2.26B
Net Income	$-29.66M
Cost of Goods Sold	$1.52B
Gross Profit	$739.87M
Operating Expenses	$2.24B
Operating Income	$22.82M
Non-Operating Income/Expense	$-101.12M
Pre-Tax Income	$-78.30M
Normalized Pre-Tax Income	$-78.30M
Income after Taxes	$-29.66M
Income from Continuous Operations	$-29.66M
Consolidated Net Income/Loss	$-29.66M
Normalized Income after Taxes	$-29.66M
EBIT	$22.82M
EBITDA	$258.43M
Weighted-Average Shares Outstanding (Basic)	24.09M
Weighted-Average Shares Outstanding (Diluted)	24.09M
Earnings per Share (EPS) (Basic)	$-1.23
Earnings per Share (EPS) (Diluted)	$-1.23
Balance Sheet Financials
Current Assets	$1.22B
Property, Plant, and Equipment	$612.91M
Long-Term Assets	$3.16B
Total Assets	$4.38B
Current Liabilities	$481.84M
Long-Term Debt	$1.58B
Long-Term Liabilities	$1.77B
Total Liabilities	$2.26B
Common Equity	$2.12B
Tangible Shareholders Equity	$-219.62M
Shareholders Equity	$2.12B
Common Shares Outstanding	24.14M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$166.20M
Cash Flow from Investing Activities	$-87.95M
Cash Flow from Financial Activities	$-35.98M
Beginning Cash	$208.78M
End Cash	$254.22M
Increase/Decrease in Cash	$45.44M
Stock-Based Compensation	$40.56M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.53
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.43
Debt to Equity Ratio	0.77
Gross Margin	32.75%
Operating Margin	1.01%
EBIT Margin	1.01%
EBITDA Margin	11.44%
Pre-Tax Profit Margin	-3.47%
Profit Margin	-1.31%
Free Cash Flow	$83.81M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.52
Inventory Turnover	2.14
Receiveable Turnover	13.98
Days Sales in Receivables	26.10
Return on Equity	-1.40%
Return on Tangible Equity	13.50%
Return on Assets	-0.68%
Return on Investments	-0.80%
Book Value Per Share	$87.96
Free Cash Flow per Share	$3.48
Operating Cash Flow per Share	$6.90

Data from Zacks Investment Research, Inc.